AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 108 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $204,000 | -16.7% | 10,870 | -14.6% | 0.07% | -15.0% |
Q4 2017 | $245,000 | +1.7% | 12,730 | -5.6% | 0.08% | 0.0% |
Q3 2017 | $241,000 | -51.0% | 13,490 | -51.0% | 0.08% | -43.3% |
Q2 2017 | $492,000 | +3.8% | 27,523 | -15.8% | 0.14% | +24.8% |
Q1 2017 | $474,000 | -1.7% | 32,683 | +25.0% | 0.11% | +2.7% |
Q4 2016 | $482,000 | -4.7% | 26,153 | -1.9% | 0.11% | -8.3% |
Q3 2016 | $506,000 | – | 26,663 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
LAM GROUP, INC. | 128,000 | $5,886,720 | 5.78% |
Beacon Harbor Wealth Advisors, Inc. | 103,095 | $4,741 | 1.58% |
Capital Impact Advisors, LLC | 15,304 | $703,831 | 1.18% |
Quantedge Capital Pte Ltd | 36,389 | $1,673,530 | 0.91% |
Mesirow Institutional Investment Management, Inc. | 183,805 | $8,453,192 | 0.86% |
Monashee Investment Management LLC | 39,461 | $1,814,811 | 0.76% |
OBERWEIS ASSET MANAGEMENT INC/ | 152,500 | $7,013,475 | 0.74% |
Granite Investment Partners, LLC | 330,911 | $15,218,597 | 0.64% |
Portolan Capital Management | 132,850 | $6,109,772 | 0.57% |
SHAKER INVESTMENTS LLC/OH | 20,795 | $956,362 | 0.53% |